Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

The disclosure by U.S. lawyer Jonathan Guynn contradicts statements by spokespeople for the Justice Department and the White House, who said last month that Abrego Garcia would stand trial and ...

LOS ANGELES (AP) — About 90 members of the California National Guard and over dozen military vehicles like Humvees are ...

The new lawsuit repeats those concerns, alleging that Kennedy and other political appointees at the U.S. Department of Health ...

The acknowledgment that the well-connected Epstein did not have a list of clients to whom underage girls were trafficked ...

Ticker: Wegovy and Zepbound prices fall; ExxonMobil and partner Qatar Energy find new natural gas deposit off Cyprus ...

A 27-year-old man was killed Monday after opening fire at a U.S. Border Patrol facility in McAllen, Texas, authoriti ...

In the Hill Country area, home to Camp Mystic and several other summer camps, searchers have found the bodies of 75 people, ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

Wegovy received U.S. Food and Drug Administration (FDA) approval and was launched in June 2021, and Zepbound entered the market in December 2023 as a new contender.

"Both Wegovy and Zepbound have demonstrated clinically significant weight reduction." "For example, if a patient has fatty liver, we will choose the GLP-1 that is proven to work best for liver ...

Key Takeaways The weight loss drug Zepbound (tirzepatide) led to 50 percent more weight loss in a 72-week trial than Wegovy (semaglutide). Participants taking Zepbound lost 50 pounds (lb) on ...